39933002: Pancreatic hormone (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Pancreatic hormone

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\Pancreatic hormone

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Pancreatic hormone

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Pancreatic hormone

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

66522017 Pancreatic hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

776481015 Pancreatic hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Pancreatic hormone	Is a	Hormone	true	Inferred relationship	Some
Pancreatic hormone	Is a	Peptide hormones and their metabolites and precursors	false	Inferred relationship	Some
Pancreatic hormone	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Pancreatic hormone (disposition)	true	Inferred relationship	Some
Pancreatic hormone	Is a	Peptide hormone	false	Inferred relationship	Some
Pancreatic hormone	Is a	Substituted amide (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Insulin isophane biphasic porcine 30/70 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin lispro biphasic (recombinant human insulin analogue) 50/50 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 10/90 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane human 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 25/75 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane human 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 20/80 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 50/50 100units/ml injection 3ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 50/50 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 15/85 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 10/90 100units/ml injection 3ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin aspart (recombinant human insulin analogue) 100units/ml injection 3ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane human 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin soluble bovine 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin soluble porcine 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin lispro biphasic (recombinant human insulin analogue) human 25/75 100units/ml injection 3ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 20/80 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 10/90 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane porcine 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 50/50 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane human 100units/ml injection 5ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane bovine 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 40/60 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin soluble human 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 25/75 100units/ml injection 5ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 40/60 100units/ml injection 3ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin soluble porcine 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane bovine 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 15/85 100units/ml injection 5ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin soluble human 100units/ml injection 5ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin glargine 100units/mL injection solution 3mL cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic porcine 30/70 100units/ml injection 1.5ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 50/50 100units/ml injection 5ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin soluble human 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin zinc suspension mixed human 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 30/70 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin glargine 100units/mL injection solution 10mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 15/85 100units/ml injection 3ml cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin lispro biphasic (recombinant human insulin analogue) 25/75 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin glargine 100units/mL injection solution 3mL prefilled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin aspart (recombinant human insulin analogue) 100units/ml inject	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin soluble bovine 100units/ml injection 10ml vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin isophane biphasic human 40/60 100units/ml injection 3ml pre-filled disposable injection device	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Pork insulin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin aspart 100units/mL prefilled pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin biphasic aspart 30/70 100units/mL injection cartridge 3mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin glargine 100iu/mL injection cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin glargine 100iu/mL injection vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin glargine 100iu/mL prefilled pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Human isophane insulin 100units/mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Product containing insulin glulisine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Product containing insulin lispro and insulin lispro protamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Isophane insulin nph + human recombinant insulin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Product containing isophane insulin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Isophane insulin nph	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin glulisine 100units/mL injection 10mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin human 100units/mL buffered regular solution injection vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Product containing fish insulin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Product containing insulin detemir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin detemir 100iu/mL prefilled pen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin detemir 100iu/mL injection cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Insulin	Is a	True	Pancreatic hormone	Inferred relationship	Some
Amylin (substance)	Is a	True	Pancreatic hormone	Inferred relationship	Some
Product containing amylin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Product containing pramlintide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Pramlintide 0.6mg/mL injection solution 5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pancreatic hormone	Inferred relationship	Some
Free insulin	Is a	False	Pancreatic hormone	Inferred relationship	Some
Recombinant human glucagon (substance)	Is a	True	Pancreatic hormone	Inferred relationship	Some

Start Page 2 of 2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
66522017	Pancreatic hormone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
776481015	Pancreatic hormone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core